Evidence map›Paper›PMID 36944716›Full record

Trial reportScientific reports2023

Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination.

Ece Tavukcuoglu, Hamdullah Yanik, Mubaida Parveen, Sila Uluturk, Mine Durusu-Tanriover, Ahmet Cagkan Inkaya, Murat Akova, Serhat Unal, Gunes Esendagli

Open access · goldFull text readRandomized Controlled TrialClinical Trial, Phase III
In one paragraph

Trial report in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ece TavukcuogluDepartment of Basic Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey.
Hamdullah YanikDepartment of Basic Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey.
Mubaida ParveenDepartment of Basic Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey.
Sila UluturkDepartment of Basic Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey.
Mine Durusu-TanrioverDepartment of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Ahmet Cagkan InkayaDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Murat AkovaDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Serhat UnalDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Gunes EsendagliDepartment of Basic Oncology, Hacettepe University Cancer Institute, 06100, Sihhiye, Ankara, Turkey. gunese@hacettepe.edu.tr.
Hacettepe University Hospital · TRHacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluates the functional capacity of CD4

Indexed as

COVID-19COVID-19 VaccinesAdjuvants, ImmunologicAluminumCD8-Positive T-LymphocytesHumansMemory T CellsProgrammed Cell Death 1 ReceptorSARS-CoV-2VaccinationVaccines, InactivatedVirionAdjuvants, ImmunologicAluminumCOVID-19 VaccinesProgrammed Cell Death 1 Receptorsinovac COVID-19 vaccineVaccines, Inactivated

Identifiers

PMID36944716
PMCPMC10028771
OpenAlexW4328126390

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read25
identifiers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.